Pertechnetate distribution in man after intravenous infusion: a compartmental model

Area of Science:

• Nuclear Medicine
• Radiopharmacology
• Physiological Kinetics

Background:

• Pertechnetate distribution is crucial for understanding its physiological behavior.
• Iodide perturbation is a known factor influencing thyroidal uptake.
• Limited data exists on long-term pertechnetate distribution and its comparison to iodide.

Purpose of the Study:

• To investigate the distribution kinetics of pertechnetate in normal volunteers over an 8-hour period.
• To assess the impact of a large iodide dose on pertechnetate distribution.
• To develop and validate a kinetic model for pertechnetate distribution.

Main Methods:

• Primed infusion technique for pertechnetate administration.
• Radioactivity measurements in plasma, saliva, urine, and external body regions.
• Intravenous administration of a large sodium iodide (NaI) dose to a subset of subjects.
• Development of a multi-compartment kinetic model incorporating physiological data.

Main Results:

• Pertechnetate distribution was monitored over 8 hours in two subject groups.
• A large NaI dose significantly reduced pertechnetate transport into the thyroid, salivary glands, and gastrointestinal tract.
• The kinetic model identified three major subsystems: thyroid, whole-body, and gastrointestinal tract.
• Pertechnetate distribution showed qualitative similarities but quantitative differences compared to iodide.
• Large bowel compartment played a significant role in long-term pertechnetate distribution, unlike iodide.

Conclusions:

• Pertechnetate distribution is complex, involving thyroid, systemic, and significant gastrointestinal compartments.
• Iodide perturbation affects pertechnetate kinetics, particularly uptake in the thyroid and GI tract.
• The kinetic model provides a framework for understanding pertechnetate behavior.
• Unlike iodide, pertechnetate's distribution in the large bowel is a key factor in long-term studies.